Exelixis (EXEL) Construction in Progress (2010 - 2017)
Exelixis (EXEL) posted quarterly Construction in Progress of $14.5 million for Q2 2017, up 3086.4% quarter-over-quarter from $456000.0 in Q4 2015.
Analysis
Exelixis (EXEL) Construction in Progress (2010 - 2017) Analysis & Trends
Exelixis' Construction in Progress history runs 7 years deep, the most recent figure standing at $14.5 million for Q2 2017.
- In Q2 2017, Construction in Progress changed N/A year-over-year to $14.5 million; the TTM figure through Jun 2017 stood at $14.5 million (changed N/A YoY), while the FY2015 annual figure was $456000.0, up 280.0% from the prior year.
- Construction in Progress for Q2 2017 stood at $14.5 million, up from $456000.0 in the prior quarter.
- The five-year high for Construction in Progress was $14.5 million in Q2 2017, with the low at $68000.0 in Q4 2013.
- The 4-year median for Construction in Progress is $288000.0 (2014), against an average of $3.8 million.
- The sharpest annual moves came in 2013 and 2015: Construction in Progress tumbled 95.17% in 2013, then jumped 280.0% in 2015.
- Exelixis' Construction in Progress stood at $68000.0 in 2013, then soared by 76.47% to $120000.0 in 2014, then surged by 280.0% to $456000.0 in 2015, then jumped by 3086.4% to $14.5 million in 2017.
- Business Quant data shows EXEL's Construction in Progress at $14.5 million in Q2 2017, $456000.0 in Q4 2015, and $120000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 152.67 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 14.53 Mn |
| Dec 31, 2015 | 456,000.00 |
| Dec 31, 2014 | 120,000.00 |
| Dec 31, 2013 | 68,000.00 |
| Dec 31, 2012 | 1.41 Mn |
| Dec 31, 2011 | 155,000.00 |
| Dec 31, 2010 | 373,000.00 |